- US-listed companies
- EAGLE PHARMACEUTICALS, INC.
- Financials
- Proceeds from issuance of term debt, net
EAGLE PHARMACEUTICALS, INC. (EGRX)
Market cap
$4.94M
P/E ratio
0.5x
| Period End | Proceeds from issuance of term debt, net (Million USD) | YoY (%) |
|---|---|---|
| Dec 31, 2022 | 50 |